Results for "Understanding Pharmaceutical Distribution"
Chip Davis Shares HDA’s 2024 Policy Priorities in Annual Chain Drug Review Column
With a presidential election on the horizon and policymakers working to develop solutions to challenges facing patients and providers, HDA’s President and CEO Chip Davis provided key insights into the association’s 2024 policy priorities in his annual column, “Health Care Outlook,” by Chain Drug Review.
Chip Davis Discusses HDA’s 2023 Priorities in Annual Chain Drug Review Column
With the welcoming of the new year and 118th Congress, HDA’s President and CEO Chip Davis penned an overview of the association’s 2023 priorities for the January 9 issue of Chain Drug Review.